Holen Sie sich die Stockscreener-App
2.02
0.49%
-0.010
Finanzdaten der Dare Bioscience Inc-Aktie (DARE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
183.27%
-0.0212
|
0.0254 | -0.0636 | 0.0417 | 0.0224 |
Operating Expenses
|
17.36%
3.8066
|
4.6065 | 5.3246 | 4.723 | 7.3819 |
| Benefits Costs and Expenses |
3.9953
|
- | 4.0618 | - | - |
| Costs And Expenses |
17.36%
3.8066
|
4.6065 | -14.07 | 4.723 | 7.3819 |
| Operating Income/Loss |
16.44%
-3.8278
|
-4.5811 | -5.3882 | -4.6813 | -7.3595 |
| Income/Loss From Continuing Operations Before Tax |
8.26%
-4.0165
|
-4.3783 | -4.1254 | 0.0417 | 12.91 |
| Income/Loss From Continuing Operations After Tax |
8.26%
-4.0165
|
-4.3783 | -5.5048 | -4.7025 | 12.91 |
|
Net Income/Loss
|
8.26%
-4.0165
|
-4.3783 | -5.5064 | -4.7025 | 12.91 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.28%
8.8712
|
8.7591 | -0.1594 | 8.5344 | 8.4112 |
| Diluted Average Shares |
1.28%
8.8712
|
8.7591 | -0.1862 | 8.5344 | 8.4762 |
| Basic Earnings Per Share |
10.00%
-0.45
|
-0.50 | -0.65 | -0.55 | 1.53 |
| Diluted Earnings Per Share |
10.00%
-0.45
|
-0.50 | -0.65 | -0.55 | 1.52 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.71%
1.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):